During the past decade, Investigaciones En Patologias Respiratorias conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Investigaciones En Patologias Respiratorias" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Investigaciones En Patologias Respiratorias" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator and "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Investigaciones En Patologias Respiratorias" are "Asthma" (3 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Acute Respiratory Infection" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Investigaciones En Patologias Respiratorias" in a lesser frequency.

Most popular intervention types in "Investigaciones En Patologias Respiratorias" are "Drug" (12 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Lebrikizumab" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Astegolimab" (1 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Investigaciones En Patologias Respiratorias" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Investigaciones En Patologias Respiratorias". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Investigaciones En Patologias Respiratorias, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Investigaciones En Patologias Respiratorias, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Investigaciones En Patologias Respiratorias has several departments that took part in Clinical trials: "Instituto de Neurociencias San Agustín" - 5 trials